Breaking news: FDA grants approval for first Alzheimer’s drug slowing disease progression

The first and only approved anti-amyloid Alzheimer’s Disease (AD) treatment shown to reduce the rate of disease progression and slow cognitive impairment has been granted approval by the FDA.